McDonnell Michael R.

SEC source: 0001127602-22-022132 · form4.xml · derivative · entry 7

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,366

Underlying: Common Stock · 3,298 shares

Expires 2023-09-01

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

F3 · derivative.exercise_date: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

SEC source: 0001127602-22-022132 · form4.xml · derivative · entry 6

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,664

Underlying: Common Stock · 2,064 shares

Expires 2023-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-22-022132 · form4.xml · derivative · entry 5

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,682

Underlying: Common Stock · 2,682 shares

Expires 2023-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 09/01/2020.

SEC source: 0001127602-22-022132 · form4.xml · nonDerivative · entry 4

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,745

SEC source: 0001127602-22-022132 · form4.xml · nonDerivative · entry 3

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,801

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-22-022132 · form4.xml · nonDerivative · entry 2

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,737

SEC source: 0001127602-22-022132 · form4.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,109

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 09/01/2020.

SEC source: 0001415889-22-005723 · form4-05262022_030527.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,050

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001127602-22-006275 · form4.xml · derivative · entry 4

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,668

Underlying: Common Stock · 2,851 shares

Expires 2024-02-18

F2 · kind: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-22-006275 · form4.xml · derivative · entry 3

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,519

Underlying: Common Stock · 1,981 shares

Expires 2024-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).

SEC source: 0001127602-22-006275 · form4.xml · nonDerivative · entry 2

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,427

SEC source: 0001127602-22-006275 · form4.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,404

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-22-004790 · form4.xml · derivative · entry 2

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,770

Underlying: Common Stock · 9,770 shares

Expires 2025-02-10

F1 · derivative.exercise_date: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.

SEC source: 0001127602-21-024863 · form4.xml · derivative · entry 7

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,728

Underlying: Common Stock · 2,038 shares

Expires 2023-09-01

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average closing stock price for the 30 calendar days following and including the grant date and 30 calendar days prior to and including such vesting date]).

F3 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-21-024863 · form4.xml · derivative · entry 6

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,766

Underlying: Common Stock · 3,324 shares

Expires 2023-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average closing stock price for the 30 calendar days following and including the grant date and 30 calendar days prior to and including such vesting date]).

SEC source: 0001127602-21-024863 · form4.xml · derivative · entry 5

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,364

Underlying: Common Stock · 2,681 shares

Expires 2023-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 09/01/2020.

SEC source: 0001127602-21-024863 · form4.xml · nonDerivative · entry 4

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,423

SEC source: 0001127602-21-024863 · form4.xml · nonDerivative · entry 3

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,864

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-024863 · form4.xml · nonDerivative · entry 2

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,540

SEC source: 0001127602-21-024863 · form4.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,681

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-006995 · form4.xml · derivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,500

Underlying: Common Stock · 14,500 shares

Expires 2024-02-18

F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).

SEC source: 0001127602-20-024721 · form4.xml · derivative · entry 2

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,090

Underlying: Common Stock · 16,090 shares

Expires 2023-09-01

F2 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average closing stock price for the 30 calendar days following and including the grant date and 30 calendar days prior to and including such vesting date]).

SEC source: 0001127602-20-024721 · form4.xml · derivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,045

Underlying: Common Stock · 8,045 shares

Expires 2023-09-01

F1 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 09/01/2020.

SEC source: 0001478242-20-000040 · primary_doc.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,966

SEC source: 0001478242-20-000012 · edgar.xml · derivative · entry 3

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,897

Underlying: Common Stock · 23,897 shares

Expires 2030-02-11

F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 11, 2021.

SEC source: 0001478242-20-000012 · edgar.xml · nonDerivative · entry 2

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,728

SEC source: 0001478242-20-000012 · edgar.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,094

F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 2, 2017. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 11, 2020.

SEC source: 0001478242-20-000002 · edgar.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,366

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 23, 2019.

F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $155.00 to $155.10 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001478242-19-000035 · edgar.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,366

SEC source: 0001127602-19-014279 · form4.xml · derivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,925.52

Underlying: Common Stock · 14,018.69 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company.

F2 · kind: Quarterly payment of portion of annual retainer paid in the form of phantom stock units.

F1 · derivative.exercise_date: Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company.

F1 · derivative.expiration_date: Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company.

SEC source: 0001478242-19-000009 · edgar.xml · derivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,045

Underlying: Common Stock · 23,045 shares

Expires 2029-02-13

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/13/2020.

SEC source: 0001127602-19-000829 · form4.xml · derivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,906.83

Underlying: Common Stock · 14,906.83 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company.

F2 · kind: Quarterly payment of portion of annual retainer paid in the form of phantom stock units.

F3 · shares: Includes payment of pro rata portion of 2018 annual retainer from date of election to the Board.

F1 · derivative.exercise_date: Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company.

F1 · derivative.expiration_date: Phantom stock units convert one-for-one into shares of common stock or cash equivalent, at the election of the Reporting Person, upon the Reporting Person's termination of service as a director of the Company.

SEC source: 0001478242-18-000062 · edgar.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,785

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2018.

F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $127.05 to $129.00 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001478242-18-000044 · edgar.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,285

SEC source: 0001478242-18-000007 · edgar.xml · derivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,742

Underlying: Common Stock · 26,742 shares

Expires 2028-02-08

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/08/2019.

SEC source: 0001478242-17-000038 · edgar.xml · nonDerivative · entry 2

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,517

SEC source: 0001478242-17-000038 · edgar.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,590

F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on July 5, 2018.

SEC source: 0001595262-17-000002 · edgar.xml · nonDerivative · entry 2

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,517

SEC source: 0001595262-17-000002 · edgar.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,590

F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on July 5, 2018.

SEC source: 0001478242-17-000007 · edgar.xml · derivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,034

Underlying: Common Stock · 26,034 shares

Expires 2027-02-02

F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/02/2018.

SEC source: 0001478242-16-000013 · edgar.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,767

F1 · shares: Reflects shares withheld for taxes upon the vesting of 9,094 RSUs on December 16, 2016.

F2 · balance_after: This amount includes 27,280 RSUs granted on December 16, 2015, and 7,732 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 3, 2016.

SEC source: 0001209191-16-144306 · doc4.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,106

F1 · security: Issuance to the reporting person of restricted stock units ("RSUs") under the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan (f/k/a the Quintiles Transnational Holdings Inc. 2013 Stock Incentive Plan) upon the conversion, at the effective time of the merger between Quintiles Transnational Holdings Inc. and IMS Health Holdings, Inc., of performance units ("PUs") originally issued to the reporting person on March 3, 2016. The PUs converted into RSUs at 100% of target, and the resulting RSUs will vest in full on December 31, 2018, the end of the original performance period of the PUs that were converted.

F2 · balance_after: This amount includes 36,374 RSUs granted on December 16, 2015 and 7,732 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 3, 2016.